Executive Summary
GoSecure seeks Director Review to vacate the institution of two IPRs filed by CrowdStrike that challenge all 21 claims of U.S. Patent 9,954,872. The patent owner alleges the Board abused discretion by allowing duplicate petitions, misapplying claim ambiguity, and incorrectly construing “computer system.”
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in CrowdStrike, Inc. et al. vs GoSecure, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Abbott Laboratories et al.vsMIRACOR MEDICAL SA
Abbott Laboratories has filed an IPR petition seeking cancellation of claims 1‑7, 10, and 12‑13 of Miracor’s U.S. Patent 11,351,356 covering a catheter‑based LVAD. The petition argues that four prior‑art references disclose every claim limitation, making the claims obvious under §103. The Board has not yet ruled on institution or denial.
Google LLCvsKove IO, Inc.
Google and Kove IO have settled their dispute over U.S. Patent 7,103,640 and filed a joint motion to terminate the pending IPR.
Samsung Electronics Co., Ltd. et al.vsHannibal IP LLC
Samsung and Hannibal IP jointly filed a motion to terminate IPR2025-01189, seeking to keep their settlement agreement confidential under statutory authority.
WHOOP, Inc.vsOmni MedSci, Inc.
The PTAB held that WHOOP proved unpatentability of 12 of the 23 claims of Omni MedSci’s wearable physiological‑measurement patent, while the remaining 11 claims were left intact. The decision hinged on obviousness over a combination of prior‑art references covering optical sensing, modulation, and AI‑driven analysis.
Innoscience America, Inc. et al.vsInfineon Technologies Americas Corp.
The PTAB denied Innoscience America's petition to institute IPR against Infineon Technologies regarding patent 9070755. The Board found that factors favoring discretionary denial, such as overlap with a parallel ITC investigation, outweighed arguments for institution.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.